Activyl

Selected form

Indoxacarb

Method of action: Ectoparaciticides, Insecticides And Repellents

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Activyl

Property	Description
Active ingredient	Indoxacarb
Form	Spot-on solution, topical
Pharmacological class	Ectoparasiticide, Oxadiazine insecticide
General purpose	Control of external parasites (e.g., fleas, lice)
Origin	Synthetic chemical compound, Pro-drug

What Kind of Medicine is Activyl and What is its Form?

Activyl is a specialized veterinary medication classified as an ectoparasiticide, meaning its primary function is to eliminate parasites living on the host animal's external surfaces. It is formulated as a non-systemic, spot-on solution for topical administration. It is classified as an antiparasitic product targeting external pests, supporting its intended role in managing infestations. The product is often positioned for use in dogs, puppies, cats, and kittens, a differentiation that underscores its broad but specific target patient group within veterinary medicine. This solution is designed to spread across the animal's skin and coat lipids, providing local delivery of the active component directly where the target pests reside.

What is the Active Ingredient: Indoxacarb, and is it Natural or Synthetic?

The core active ingredient in Activyl is Indoxacarb, a synthetic chemical compound belonging to the Oxadiazine class of insecticides. Indoxacarb is scientifically categorized as a voltage-gated sodium channel blocker that disrupts nerve signal transmission in target organisms. The compound is characterized by its specific and potent action against parasitic insects. Furthermore, it functions as a pro-drug—it is chemically inactive until it is metabolized by specific enzymes found only within the pest itself. This pro-drug characteristic is a key differentiating feature of the formulation, distinguishing its mechanism from many older, direct-acting insecticides.

What is Activyl's General Purpose?

The general purpose of Activyl is to achieve effective control of external parasites by utilizing Indoxacarb's unique, metabolism-dependent mode of action. Because the active form of the substance only develops inside the parasite, the resulting targeted neural disruption quickly incapacitates pests like fleas and lice. This action helps to eliminate existing adult parasites, resolve the infestation, and, by preventing the survival of the pests, aids in the interruption of the parasite life cycle in the animal's immediate environment. A typical use scenario involves application as part of a routine regimen to manage flea infestation.

What side effects are possible with Activyl?

Possible side effects and safety information

The safety profile for this spot-on solution is established by government regulatory documentation, which classifies possible adverse reactions by frequency and affected physiological system. All documented safety characteristics are derived from official clinical data.

Adverse Reactions and Frequency Classification

Adverse reactions are classified by the physiological system affected and the frequency with which they are reported.

Classification	System-Organ Class Affected	Documented Adverse Reactions
Very Rare (Less than 1 in 10,000 animals treated)	General Disorders and Administration Site Conditions	Hypersalivation, local reactions (scratching, erythema, alopecia, dermatitis).
Rare (More than 1 but less than 10 in 1,000 animals treated)	Gastrointestinal & Nervous System Disorders (in cats)	Emesis, anorexia, and reversible neurological signs (incoordination, tremor, ataxia, mydriasis).

Hypersalivation is documented as a brief, transient effect occurring immediately if the application site is licked. Local application site effects, such as a temporary oily appearance, hair clumping, or dry white residue, are considered common physical findings that usually resolve without intervention.

Safety Restrictions and Special Populations

Safety data have not been established for the use of this product in several specific groups, and its use is not recommended for animals:

Younger than 8 weeks of age.
Under a specified minimum weight (1.5 kg for dogs, 0.6 kg for cats).
That are pregnant, lactating, or intended for breeding.

The product is contraindicated in cases of known hypersensitivity to the active ingredient, Indoxacarb. No other high-level interaction-related adverse reactions have been documented in official regulatory texts.

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information for Activyl

This information is derived from official governmental regulatory documents (e.g., EMA/EPAR) regarding the overdose profile of Activyl (Indoxacarb) and its combination products.

Documented Overdose Manifestations

Studies show high tolerance in target species (dogs and cats) to the active ingredient, with no adverse effects documented at doses up to five times the recommended level. Overdose-related symptoms, occurring in rare cases following exposure such as licking, are generally mild and reversible. These documented signs may include gastrointestinal issues (emesis, anorexia) and transient neurological signs like tremor, ataxia, or lethargy.

Serious Risks and Emergency Actions

The primary serious risk is documented for cats accidentally exposed to the Permethrin-containing combination product (Activyl Tick Plus), as this substance is extremely poisonous to them and can induce potentially fatal convulsions.

Accidental Exposure Type	Required Emergency Action (as per Label)
Cat exposed to Permethrin combination	Wash the cat with shampoo or soap and seek veterinary advice rapidly.
Human exposure with symptoms	Seek medical advice and show the package leaflet to the physician.

Hypersalivation from licking the application site is a transient effect, not considered a sign of intoxication, and typically resolves without intervention.

Therapeutic Uses of Activyl

What Activyl Treats: Main Uses and Benefits

Activyl is commonly used across domains where additional symptomatic support is needed to manage flea infestations caused by adult Ctenocephalides felis. This ectoparasiticide is relevant for easing symptoms related to physical discomfort that result from the presence of external parasites.

The medication is applied in addressing acute symptomatic episodes, primarily targeting three key areas: is relevant for managing flea infestations, is used for managing symptoms of pruritus (itching), and acting as part of a management strategy for Flea Allergy Dermatitis (FAD). It helps address symptom clusters that may become intense or disruptive, such as the initial parasite burden and subsequent symptomatic manifestations associated with self-trauma.

The product may be applied in clinical settings that involve acute or unstable symptom patterns, as well as in routine, preventative health regimens for recurrent or episodic manifestations. A key benefit may provide supportive relief when symptoms interfere with routine activities, and it contributes to improved comfort during periods of heightened symptoms.

Quick Fact: Symptomatic support for Pruritus (Itching)

Regulatory References

European Commission/EMA Product Information

Eligibility and Restrictions for Use

Who can and cannot use Activyl?

Eligibility for Activyl (Indoxacarb) is strictly defined by regulatory authorities and is conditional on the animal's species, age, weight, and physiological status. The medicine is formally approved for use in dogs and cats, including puppies and kittens aged 8 weeks or older.

Absolute Contraindications and Restrictions

Use of Activyl is strictly contraindicated in several specific populations:

Animals with known hypersensitivity to the active substance, Indoxacarb, or any excipients.
Cats must not use the product that contains Permethrin (e.g., Activyl Tick Plus), as this combination is potentially fatal.
Animals that are pregnant or intended for breeding (fertility) must not be treated, as safety has not been established in these groups.
Lactating dogs must not use the product; use in lactating cats is not recommended.

Pediatric and Weight-Based Limits

Safety has not been established in animals younger than 8 weeks of age or in those weighing below the minimum threshold (e.g., 1.5 kg for dogs or 0.6 kg for cats, depending on the specific formulation). Eligibility requires the animal to meet both the minimum age and weight limits.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Activyl (Indoxacarb) is defined by a lack of formally documented interactions, according to authoritative government product information. The regulatory labeling explicitly states that the interaction profile with other medicinal products and substances is classified as None known. This regulatory assessment forms the basis for the product's official standing regarding combination use.

Interaction Profile Summary

Due to this official finding, the product’s interaction documentation contains no formal restrictions or required constraints for co-administration. This summary reflects the specific data noted in the regulatory labeling:

Contraindicated Combinations: No specific medicinal products or substance classes are listed as being formally contraindicated for use alongside Activyl based on interaction risk.
Metabolic and Pharmacodynamic Interactions: No alterations in exposure, such as changes to clearance or plasma levels, or additive/synergistic effects are documented in the official labeling. The documents do not specify any known metabolic interactions (e.g., CYP enzyme effects) or transporter-mediated interactions that would alter the drug's regulatory profile.
Timing Requirements: No mandatory separation intervals or specific timing requirements for administering Activyl relative to other medications are specified in the regulatory documentation. The product labeling also states no known interactions with food, alcohol, or herbal products.

Documented Co-administration Context

Clinical studies were conducted to assess co-administration with other external antiparasitics. These studies specifically documented the use of Activyl alongside deltamethrin collars without any evidence of associated adverse reactions being observed. This structure confirms that the overall regulatory assessment does not impose constraints or prohibitions tied to the drug's interaction profile.

Mechanism of Action

How Activyl Works

This section explains the action of Indoxacarb by detailing the biological targets and molecular events that lead to the drug's effect profile in the target parasite. The mechanism is characterized by a unique two-step process: bioactivation followed by rapid neural disruption.

️ Activation and Selective Action (Pro-Drug Mechanism)

Activyl's core mechanism relies on enzymatic bioactivation. The molecule is a pro-drug, meaning it is chemically inactive until it is converted inside the pest. Only specific insect metabolic enzymes are capable of performing the necessary cleavage, which transforms the parent compound into a highly active neurotoxic metabolite. This dependence on unique pest enzymes is a key factor contributing to the difference in mechanistic outcome between the target pest and non-target organisms and limits the mechanism's functional relevance outside the target pest.

Sodium Channel Blockade and Paralysis

The active metabolite primarily targets voltage-gated sodium channels within the insect's central nervous system (CNS). By binding to these channels, the metabolite prevents them from closing, essentially trapping them in an open or non-inactivating state. This uncontrolled influx of sodium ions disrupts the fundamental pathway of neuronal signal transmission, leading to acute neurotoxicity and the systemic disruption of motor control. This systemic neural disruption results in motor paralysis and physical cessation of activity in the parasite.

Dosage and Administration Information

How Activyl Is Used

The administration of Activyl (Indoxacarb) is established as a topical, non-systemic solution for application to the skin surface. The medication is provided in pre-sized, unit-dose pipettes and must not be administered orally or via any other route.

Administration and Dosing Principles

The core of the usage pattern is the species-specific minimum dose, determined by body weight, which dictates the size of the required unit-dose pipette. This approach ensures delivery of the appropriate dose for ongoing parasite control.

Species	Minimum Recommended Dose
Dogs	15 mg Indoxacarb per kg body weight
Cats	25 mg Indoxacarb per kg body weight

Schedule and Procedural Constraints

Activyl is used as part of a long-term, intermittent treatment plan, with a single application providing sustained control against further infestation for a period of at least four weeks. Subsequent applications must be scheduled with a minimum four-week interval to maintain the protocol.

Use is restricted to animals that are 8 weeks of age or older and meet the weight minimums for their dose size. For proper administration, the solution must be applied to intact skin at a site where the animal cannot lick it off, such as the base of the skull or between the shoulder blades. This procedural constraint is required to prevent accidental oral exposure.

Recent Clinical Evidence

Research evidence / Overview of Studies for Activyl

Evidence for use in Treating Flea Infestation

The research exploring the product was studied for measurements related to adult fleas, a key target in research for this type of medication. Researchers conducted controlled laboratory studies and blinded field trials involving client-owned dogs and cats. These studies research examined outcomes such as the speed of action following application, the percentage of change in flea counts on the animals, and the proportion of treated animals that achieved a flea count of zero. Studies reported measurements of change in flea counts in the hours following application. Field trials described patterns where the majority of animals achieved and maintained a flea count of zero over the intermediate-term (28-to-30-day cycle). These findings were used by regulators to characterize the product’s performance related to adult flea burden measurements during periods of use. The research included puppies and kittens whose inclusion in the studies was specified by minimum age and weight criteria.

Evidence for use in Interrupting the Flea Life Cycle and FAD

Studies explored the substance’s activity against non-adult flea stages, using controlled laboratory assays to measure the effect on flea egg viability (ovicidal activity). Environmental assessments documented that the data show patterns related to a change in the development of flea larvae and pupae in the immediate surroundings of the treated animal. These findings contribute to the broader evidence landscape by providing context on how the product may address the environmental source of the infestation. The product was evaluated in studies as part of a treatment strategy for Flea Allergy Dermatitis (FAD); regulatory review for this indication is fundamentally supported by research confirming the product's performance in flea count elimination.

Research Gaps and Uncertainty

The existing evidence highlights several areas where the research remains incomplete. Long-term effects are not fully established through continuous trials extending over many months, as most data focuses on the intermediate-term monthly cycle. Comparative evidence is lacking from large, independent, head-to-head trials against all modern control products. Additionally, the evidence quality varies across studies, with observational field studies being more prone to variables like owner compliance compared to controlled laboratory trials.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Activyl (FAQ)

Q: What should I do if my cat licks the application site?

If a cat licks the application site immediately after treatment, official product information indicates that it may cause a brief period of hypersalivation (excessive drooling). Official product information notes that this effect is generally temporary. While it is not considered a sign of systemic intoxication, any concerns or persistent effects should still be directed to a veterinarian.

Q: How fast does Activyl start killing fleas?

Official studies show that the active ingredient causes a rapid cessation of feeding in fleas within 0 to 4 hours after treatment. This neural disruption is then followed by paralysis and death, typically occurring within 4 to 48 hours.

Q: Is Activyl waterproof, and can my dog go swimming after application?

Regulatory documents indicate that the product maintains its effectiveness after exposure to water, such as bathing or swimming. However, the label specifies a necessary waiting period, and animals should not be allowed to swim or be shampooed during the first 48 hours following application.

Q: Does Activyl kill ticks, or only fleas?

According to the official product information, Activyl is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis). The regulatory labeling does not include indications for the control or killing of ticks.

Q: How long do I need to wait between applications of Activyl?

Official information indicates that a single application provides sustained protection against new flea infestations for a period of at least four weeks. The regulatory treatment schedule is established based on providing efficacy for that full 4-week period.

How should Activyl be stored and disposed of?

How to Store and Dispose of Activyl?

The official storage and disposal guidelines for Activyl are set by regulatory authorities and must be followed to maintain product stability and ensure environmental safety.

Storage Requirements

Storage Component	Official Requirement
Temperature	No special temperature conditions are required.
Packaging	Store pipettes in the original package to protect from moisture.
Safety	Must be kept out of the sight and reach of children. The sachet is child-resistant.
Flammability	Keep away from heat, sparks, open flame, or other ignition sources.
Stability	The product has a shelf life of 4 years when stored in its original, unopened packaging.

Disposal Requirements

Disposal of any unused product or waste materials must be carried out in accordance with local requirements. Due to the formulation's potential danger to aquatic organisms, Activyl should not be allowed to enter water courses (surface waters) or drains. Used pipettes should be disposed of immediately.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.